Cleared Traditional

K233751 - Milieve (YPS-301BD)

K233751 is an FDA 510(k) clearance for Milieve (YPS-301BD), manufactured by Soterix Medical, Inc.. The device is a Class 2 Neurology device with product code PCC cleared through the Traditional 510(k) pathway after a 194-day FDA review.

K233751 · Soterix Medical, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
194d
Days
Class 2
Risk

K233751 is an FDA 510(k) clearance for the Milieve (YPS-301BD). Classified as Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (product code PCC), Class II - Special Controls.

Submitted by Soterix Medical, Inc. (Woodbridge, US). The FDA issued a Cleared decision on June 3, 2024 after a review of 194 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5891 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Soterix Medical, Inc. devices

FDA 510(k) Submission Details - K233751

510(k) Number K233751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2023
Decision Date June 03, 2024
Days to Decision 194 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d slower than avg
Panel avg: 148d · This submission: 194d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PCC Device Classification - Class 2, Special Controls

Product Code PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine

All 13
Devices cleared under the same product code (PCC) and FDA review panel - the closest regulatory comparables to K233751.
ELEXIR 2.0 (ALLIVE3)
K242719 · Nu Eyne Co., Ltd. · Nov 2024
CEFALY Connected - OTC, CEFALY Connected - Rx
K234029 · Cefaly Technology · Jul 2024
DOOPANG
K232749 · Ybrain, Inc. · Jun 2024
TENS device-HeadaTerm 2 (Model: YF-HT2)
K230782 · Wat Medical Technology, Inc. · Feb 2024
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
K212071 · Cefaly Technology · Dec 2022
Relivion
K212106 · Neurolief , Ltd. · Aug 2021